Innovative Product Portfolio Acro Biotech specializes in a diverse range of FDA-approved rapid diagnostic tests including women’s health, cardiac markers, tumor markers, and infectious disease tests, presenting opportunities to supply or collaborate on new test developments aligned with global health trends.

Accredited Manufacturing Excellence Operating from ISO13485:2003 and CMDCAS-compliant facilities, Acro Biotech offers high-quality manufacturing services that appeal to international clients seeking reliable and compliant rapid test production capabilities.

Growing Market Presence With a focus on international markets and a product lineup aligned with global health needs, there is potential to expand distribution partnerships and enter new geographic regions actively seeking reliable rapid diagnostic solutions.

Technology Stack Leverage Utilizing advanced cloud and web technologies like Google Cloud CDN, PHP, and MySQL, Acro Biotech can enhance digital marketing and e-commerce platforms to better reach and engage potential global customers and partners.

Market Expansion Opportunities Given the company’s relatively modest revenue of under $1 million and niche specialization, there are significant growth prospects through strategic partnerships, funding avenues, and expanding product offerings in high-demand health segments.